Two leading biotech players — Bengaluru-based Biocon Biologics Limited and Pune-based Serum Institute Life Sciences Private Ltd — have come together in a strategic alliance in a bid to increase vaccines and antibody therapeutics access for developing countries, for infectious diseases, including Covid-19, dengue and HIV.